Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Nuvalent Inc NUVL

Healthcare Biotechnology
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase... see more

Current News (NDAQ:NUVL)

Nuvalent Appoints Ron Squarer to Board of Directors

PR Newswire 6 days ago

Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference

PR Newswire November 26, 2025

Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders

PR Newswire November 24, 2025

Nuvalent Announces FDA Acceptance of New Drug Application for Zidesamtinib for the Treatment of TKI Pre-treated Patients with Advanced ROS1-positive NSCLC

PR Newswire November 19, 2025

Nuvalent Announces Pricing of Public Offering of Common Stock

PR Newswire November 18, 2025

Nuvalent Announces Public Offering of Common Stock

PR Newswire November 17, 2025

Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC

PR Newswire November 17, 2025

Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib

PR Newswire November 14, 2025

Nuvalent to Present Patient-Reported Outcomes Data from ARROS-1 Trial of ROS1-Selective Inhibitor, Zidesamtinib, at 2025 IASLC ASCO North America Conference on Lung Cancer

PR Newswire November 4, 2025
View More News ››

Opinion & Analysis (NDAQ:NUVL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NUVL)

Nuvalent, Inc. (NASDAQ:NUVL): A Promising Oncology Biotech w

http://beyondspx.com/2024/08/01/nuvalent-inc-nasdaqnuvl-a-promising-oncology-biotech-with-innovative-precision-therapies/
MikeTester - August 2, 2024

eiger and nixxo

New to this board. any ideas when these two will start to work together in producing effective business in saling real products to real...
mercure - March 3, 2001

Harmony and Nixxo

eiger technology (AXA) is playing a major part in all of this. Best thing I can suggest is for those interested to go to SEDAR and print...
metmr - February 22, 2001

RE: new info on this board from CANADA EH?

Ive heard that nixxo may not be using harmony as their shell to go public. Has anyone heard similar rumours.
redln - February 10, 2001

new info on this board from CANADA EH?

Nixxo 25% owned by Eiger axa on the Toronto exchange. You will get more onfo re merger and the type of things you can see Harmony doing....
metmr - February 8, 2001

Could hit $5 soon!!!!

My close source says this could hit $5 soon, and to keep my eye on it. I can't believe, I have known about this stock since it was...
diggler69 - December 11, 2000
View more Bullboard ››

Vesalius Longevity Labs

Vesalius Longevity Labs

View More »